Delayed maturation of cytochrome P450 3A (CYP3A) activity in vivo in the first year of life

被引：0
|
作者：
Leeder, JS
Adcock, K
Gaedigk, A
Gotschall, R
Wilson, JT
Kearns, GL
机构：
[1] Childrens Mercy Hosp, NICHD, PPRU, Kansas City, MO 64108 USA
[2] Louisiana State Univ, Med Ctr, NICHD, PPRU, Shreveport, LA USA
来源：
PEDIATRIC RESEARCH | 2000年 / 47卷 / 04期
关键词：
D O I：
暂无
中图分类号：
R72 [儿科学];
学科分类号：
100202 ;
摘要：
2788
引用
收藏
页码：472A / 472A
页数：1
相关论文
共 50 条
  • [31] BUDESONIDE IS METABOLIZED BY CYTOCHROME-P450 3A (CYP3A) ENZYMES IN HUMAN LIVER
    JONSSON, G
    ASTROM, A
    ANDERSSON, P
    DRUG METABOLISM AND DISPOSITION, 1995, 23 (01) : 137 - 142
  • [32] In vivo induction of cytochrome p450 CYP3A expression in rat leukocytes using various inducers
    Mahnke, A
    Roos, PH
    Hanstein, WG
    Chabot, GG
    BIOCHEMICAL PHARMACOLOGY, 1996, 51 (11) : 1579 - 1582
  • [33] Characterization of equine cytochrome P450: role of CYP3A in the metabolism of diazepam
    Nakayama, S. M. M.
    Ikenaka, Y.
    Hayami, A.
    Mizukawa, H.
    Darwish, W. S.
    Watanabe, K. P.
    Kawai, Y. K.
    Ishizuka, M.
    JOURNAL OF VETERINARY PHARMACOLOGY AND THERAPEUTICS, 2016, 39 (05) : 478 - 487
  • [34] Induction of intestinal cytochrome P450 (CYP3A) by rifampicin in beagle dogs
    Kyokawa, Y
    Nishibe, Y
    Wakabayashi, M
    Harauchi, T
    Maruyama, T
    Baba, T
    Ohno, K
    CHEMICO-BIOLOGICAL INTERACTIONS, 2001, 134 (03) : 291 - 305
  • [35] In vitro and in vivo Inhibitory Effects of Glycyrrhetinic Acid on Cytochrome P450 3A Activity
    Li, Hai Yun
    Xu, Wen
    Su, Juan
    Zhang, Xi
    Hu, Li Wei
    Zhang, Wei Dong
    PHARMACOLOGY, 2010, 86 (5-6) : 287 - 292
  • [36] Clinical Drug-Drug Interactions Through Cytochrome P450 3A (CYP3A) for the Selective ALK Inhibitor Alectinib
    Morcos, Peter N.
    Cleary, Yumi
    Guerini, Elena
    Dall, Georgina
    Bogman, Katrijn
    De Petris, Luigi
    Viteri, Santiago
    Bordogna, Walter
    Yu, Li
    Martin-Facklam, Meret
    Phipps, Alex
    CLINICAL PHARMACOLOGY IN DRUG DEVELOPMENT, 2017, 6 (03): : 280 - 291
  • [37] RENAL AND HEPATIC FAMILY 3A CYTOCHROMES P450 (CYP3A) IN SPONTANEOUSLY HYPERTENSIVE RATS
    GHOSH, SS
    BASU, AK
    GHOSH, S
    HAGLEY, R
    KRAMER, L
    SCHUETZ, J
    GROGAN, WM
    GUZELIAN, P
    WATLINGTON, CO
    BIOCHEMICAL PHARMACOLOGY, 1995, 50 (01) : 49 - 54
  • [38] Using the Cynomolgus monkey as a model to assess cytochrome P450 3A (CYP3A) induction potential prior to first-in man: A case study
    Fura, Aberra
    Kim, Sean
    Obermeier, Mary
    Yang, Zheng
    Rodrigues, David
    DRUG METABOLISM REVIEWS, 2011, 43 : 98 - 99
  • [39] Unchanged cytochrome P450 3A (CYP3A) expression and metabolism of midazolam, triazolam, and dexamethasone in mdr(-/-) mouse liver microsomes
    Perloff, MD
    von Moltke, LL
    Cotreau, MM
    Greenblatt, DJ
    BIOCHEMICAL PHARMACOLOGY, 1999, 57 (11) : 1227 - 1232
  • [40] A Comprehensive Investigation of Dog Cytochrome P450 3A (CYP3A) Reveals a Functional Role of Newly Identified CYP3A98 in Small Intestine
    Uno, Yasuhiro
    Jikuya, Shiori
    Noda, Yutaro
    Murayama, Norie
    Yamazaki, Hiroshi
    DRUG METABOLISM AND DISPOSITION, 2023, 51 (01) : 38 - 45
12345